EcoDrugPlus

Cyclin Dependent Kinase 5

Ensembl ID : ENSMMDG00005018899
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSMMDG00005012151
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSMMDG00005008742
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSMMDG00005003506
Gene Symbol: CDK9
1 Cross references
206 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSMMDG00005002042
Gene Symbol: CDK9
1 Cross references
206 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMMDG00005018300
Gene Symbol: CYSLTR1
1 Cross references
176 Possible Orthologues:

Cytidine Deaminase A

Ensembl ID : ENSMMDG00005004155
Gene Symbol: CDAA
1 Cross references
155 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSMMDG00005004090
Gene Symbol: LOC115362725
3 Cross references
155 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSMMDG00005004949
Gene Symbol: LOC115359135
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSMMDG00005005700
Gene Symbol: LOC115378341
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSMMDG00005007374
Gene Symbol: LOC115361885
2 Cross references
445 Possible Orthologues:

Cytochrome P450 3a56-Like

Ensembl ID : ENSMMDG00005002016
Gene Symbol: LOC115362232
3 Cross references
555 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).